|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0002697,
umls-concept:C0010186,
umls-concept:C0012963,
umls-concept:C0018801,
umls-concept:C0019993,
umls-concept:C0030705,
umls-concept:C0205178,
umls-concept:C0205265,
umls-concept:C0220812,
umls-concept:C0332293,
umls-concept:C1272753,
umls-concept:C1555582,
umls-concept:C1556094,
umls-concept:C1707455
|
|
pubmed:dateCreated |
2008-4-4
|
|
pubmed:abstractText |
Phosphodiesterase (PDE) III inhibitor therapy is effective for treatment of acute decompensated heart failure (ADHF). Nevertheless, this drug is expensive than conventional inotropic agent dobutamine. We compared total medication costs of the patients treated with PDE III inhibitor amrinone therapy to that of the patients treated with conventional dobutamine therapy during initial hospitalization.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1524-4733
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
11 Suppl 1
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
S39-42
|
|
pubmed:meshHeading |
pubmed-meshheading:18387066-Aged,
pubmed-meshheading:18387066-Amrinone,
pubmed-meshheading:18387066-Cardiotonic Agents,
pubmed-meshheading:18387066-Chi-Square Distribution,
pubmed-meshheading:18387066-Cost-Benefit Analysis,
pubmed-meshheading:18387066-Dobutamine,
pubmed-meshheading:18387066-Drug Costs,
pubmed-meshheading:18387066-Economics, Pharmaceutical,
pubmed-meshheading:18387066-Female,
pubmed-meshheading:18387066-Heart Failure,
pubmed-meshheading:18387066-Hospital Costs,
pubmed-meshheading:18387066-Humans,
pubmed-meshheading:18387066-Japan,
pubmed-meshheading:18387066-Length of Stay,
pubmed-meshheading:18387066-Male,
pubmed-meshheading:18387066-Statistics, Nonparametric
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Comparison of the initial hospitalization costs between the patients treated with dobutamine and the patients treated with amrinone for acute decompensated heart failure in a Japanese institute.
|
|
pubmed:affiliation |
Department of Cardiovascular Dynamics, Research Institute, National Cardiovascular Center, Fujishirodai, Suita, Japan. kkoma@hsp.ncvc.go.jp
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
